Teva Pharmaceutical Industries (NYSE:TEVA) 2025 Conference Transcript

Teva Pharmaceutical Industries (NYSE:TEVA) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsRichard Francis - CEOConference Call ParticipantsDennis Ding - Biotech and Pharma AnalystDennis DingWelcome to the Jefferies London Healthcare Conference. My name is Dennis Ding, Biotech and Pharma Analyst here at Jefferies, and I have the wonderful pleasure of having Richard Francis here, CEO of Teva. Welcome.Richard FrancisThank you. Thank you very much for having me.Dennis DingObviously, you know, ...